发明名称 |
Utilization of phosphatidylserine in the treatment of attention deficit syndrome (adhs) |
摘要 |
The invention concerns the use of phosphatidylserine (PS), lyso-phosphatidylserine or/and a physiologically acceptable salt thereof for the treatment of the attention deficit syndrome (ADHS) in small daily doses over a longer time period and in larger daily doses over a short period as well as in combination with suitable additives selected from the group comprising antioxidants, essential fatty acids, mineral substances, amino acids, mood-lifters or/and phospholipids. In this connection it is preferred to carry out the administration to probands aged 2 to 20 years preferably 3 to 10 years whereby the phosphatidylserine as well as the additives are used in solid and also in liquid formulations. Due to its positive properties phosphatidyl-serine is in particular suitable as a therapeutic agent or food supplement in connection with ADHS. The good tolerance of phosphatidylserine even in high doses and over a longer supplementation period and the excellent compliance should also be stressed.
|
申请公布号 |
US2004235795(A1) |
申请公布日期 |
2004.11.25 |
申请号 |
US20040491636 |
申请日期 |
2004.06.24 |
申请人 |
JAGER RALF;BOKENKAMP DIRK |
发明人 |
JAGER RALF;BOKENKAMP DIRK |
分类号 |
A61K9/10;A23L1/30;A61K9/14;A61K31/07;A61K31/198;A61K31/20;A61K31/201;A61K31/355;A61K31/375;A61K31/385;A61K31/525;A61K31/683;A61K31/685;A61K33/06;A61K36/18;A61K45/00;A61K47/04;A61K47/10;A61K47/12;A61K47/26;A61P3/02;A61P3/12;A61P3/14;A61P25/00;A61P25/14;A61P25/18;A61P25/22;A61P25/28;A61P43/00;(IPC1-7):A61K31/685 |
主分类号 |
A61K9/10 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|